Lido Advisors, LLC Amphastar Pharmaceuticals, Inc. Transaction History

Lido Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$44.49 - $62.93 $57,436 - $81,242	-1,291 Reduced 26.6%	3,562 $220,000
Q3 2023 Nov 14, 2023	SELL	$45.51 - $65.0 $77,640 - $110,890	-1,706 Reduced 26.01%	4,853 $223,000
Q2 2023 Aug 09, 2023	BUY	$35.77 - $58.38 $234,615 - $382,914	6,559 New	6,559 $376,000
Q2 2022 Aug 15, 2022	SELL	$29.79 - $42.29 $409,046 - $580,683	-13,731 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$22.96 - $36.45 $315,263 - $500,494	13,731 New	13,731 $492,000

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lido Advisors, LLC with notifications on news.